Derivation of cancer diagnostic and prognostic signatures from gene expression data

Bioanalysis

Volumn 2, Issue 5, 2010, Pages 855-862

  Goodison, Steve ^a   Sun, Yijun ^b   Urquidi, Virginia ^b  

^a M D ANDERSON CANCER CENTER ORLANDO   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; DISTANT METASTASIS; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ALGORITHM; GENETIC MODEL; HIGH THROUGHPUT SCREENING; HUMAN; INTERMETHOD COMPARISON; MICROARRAY ANALYSIS; PREDICTION; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; REVIEW; SENSITIVITY AND SPECIFICITY; BREAST TUMOR; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; MALE; METHODOLOGY; NEOPLASM; PROSTATE TUMOR;

BREAST NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROSTATIC NEOPLASMS;

EID: 79952526514     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.10.35     Document Type: Review

References (61)

1. Mook S, Schmidt MK, Rutgers EJ et al. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study. Lancet Oncol. 10(11), 1070-1076 (2009).
2. Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large b-cell lymphoma identified by gene expression profiling. Nature 403(6769), 503-511 (2000). (Pubitemid 30082188)
3. Alizadeh AA, Ross DT, Perou CM, Van de Rijn M. Towards a novel classification of human malignancies based on gene expression patterns. J. Pathol. 195(1), 41-52 (2001). (Pubitemid 32899044)
4. Sotiriou C, Neo SY, McShane LM et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc. Natl Acad. Sci. USA 100(18), 10393-10398 (2003). (Pubitemid 37071889)
5. Sorlie T, Tibshirani R, Parker J et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl Acad. Sci. USA 100(14), 8418-8423 (2003). (Pubitemid 36842560)
6. Perou CM, Sorlie T, Eisen MB et al. Molecular portraits of human breast tumours. Nature 406(6797), 747-752 (2000).
7. Golub TR, Slonim DK, Tamayo P et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286(5439), 531-537 (1999).
8. Van't Veer LJ, Dai H, Van De Vijver MJ et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(6871), 530-536 (2002). (Pubitemid 34130608)
9. Van de Vijver MJ, He YD, Van't Veer LJ et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347(25), 1999-2009 (2002). (Pubitemid 35461656)
10. Singh D, Febbo PG, Ross K et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1(2), 203-209 (2002). (Pubitemid 41039166)
11. Stephenson AJ, Smith A, Kattan MW et al. Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy. Cancer 104(2), 290-298 (2005). (Pubitemid 40993255)
12. Latulippe E, Satagopan J, Smith A et al. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 62(15), 4499-4506 (2002). (Pubitemid 34827314)
13. Buyse M, Loi S, Van't Veer L et al. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J. Natl Cancer Inst. 98(17), 1183-1192 (2006). (Pubitemid 44390989)
14. Desmedt C, Piette F, Loi S et al. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the transbig multicenter independent validation series. Clin. Cancer Res. 13(11), 3207-3214 (2007). (Pubitemid 46944903)
15. Wang Y, Klijn JG, Zhang Y et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365(9460), 671-679 (2005). (Pubitemid 40260888)
16. Eifel P, Axelson JA, Costa J et al. National Institutes of Health consensus development conference statement: adjuvant therapy for breast cancer, november 1-3, 2000. J. Natl Cancer Inst. 93(13), 979-989 (2001).
17. Gevaert O, De Smet F, Timmerman D, Moreau Y, De Moor B. Predicting the prognosis of breast cancer by integrating clinical and microarray data with bayesian networks. Bioinformatics 22(14), e184-190 (2006).
18. Rouzier R, Perou CM, Symmans WF et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin. Cancer Res. 11(16), 5678-5685 (2005). (Pubitemid 41170290)
19. Loi S, Sotiriou C, Buyse M et al. Molecular forecasting of breast cancer: time to move forward with clinical testing. J. Clin. Oncol. 24(4), 721-722; author reply 722-723 (2006).
20. Cardoso F, Van't Veer L, Rutgers E, Loi S, Mook S, Piccart-Gebhart MJ. Clinical application of the 70-gene profile: the mindact trial. J. Clin. Oncol. 26(5), 729-735 (2008). (Pubitemid 351264385)
21. Weigelt B, Peterse JL, Van't Veer LJ. Breast cancer metastasis: markers and models. Nat. Rev. Cancer 5(8), 591-602 (2005). (Pubitemid 41081385)
22. Weigelt B, Baehner FL, Reis-Filho JS. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. J. Pathol. 220(2), 263-280 (2010).
23. Sawyers CL. The cancer biomarker problem. Nature 452(7187), 548-552 (2008). (Pubitemid 351483368)
24. Brenton JD, Carey LA, Ahmed AA, Caldas C. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J. Clin. Oncol. 23(29), 7350-7360 (2005). (Pubitemid 46202348)
25. Wirapati P, Sotiriou C, Kunkel S et al. Meta-analysis of gene expression profiles in breast cancer: toward a unified understandingof breast cancer subtyping and prognosis signatures. Breast Cancer Res. 10(4), R65 (2008).
26. Boulesteix Al, Porzelius C, Daumer M. Microarray-based classification and clinical predictors: on combined classifiers and additional predictive value. Bioinformatics 24(15), 1698-1706 (2008).
27. Sun Y, Goodison S, Li J, Liu L, Farmerie W. Improved breast cancer prognosis through the combination of clinical and genetic markers. Bioinformatics 23(1), 30-37 (2007). (Pubitemid 46017852)
28. Trunk GV. A problem of dimensionality: a simple example. IEEE Trans. Pattern Anal. Mach. Intell. 1(3), 306-307 (1979).
29. Clarke R, Ressom HW, Wang A et al. The properties of high-dimensional data spaces: implications for exploring gene and protein expression data. Nat. Rev. Cancer 8(1), 37-49 (2008).
30. Satagopan JM, Panageas KS. A statistical perspective on (Pubitemid 36163599)
31. Allison DB, Cui X, Page GP, Sabripour M. Microarray data analysis: from disarray to consolidation and consensus. Nat. Rev. Genet. 7(1), 55-65 (2006). (Pubitemid 41828948)
32. Dudoit S, Fridlyand J, Speed T. Comparison of discrimination methods for the classification of tumors using gene expression data. J. Am. Stat. Assoc. 97(457), 77-87 (2002).
33. Kohavi R, John G. Wrappers for feature subset selection. Artif. Intell. 97(1-2), 273-324 (1997). (Pubitemid 127401107)
34. Meyer PE, Schretter C, Bontempi G. Information-theoretic feature selection in microarray data using variable complementarity. IEEE J. Sel. Top Signal Process 2(3), 261-274 (2008).
35. Ng V, Breiman L. Bivariate variable selection for classification problem. Technical Report. Department of Statistics, University of California-Berkeley, CA, USA (2005).
36. Li T, Zhang C, Ogihara M. A comparative study of feature selection and multiclass classification methods for tissue classification based on gene expression. Bioinformatics 20(15), 2429-2437 (2004). (Pubitemid 39429915)
37. Roweis ST, Saul LK. Nonlinear dimensionality reduction by locally linear embedding. Science 290(5500), 2323-2326 (2000). (Pubitemid 32041578)
38. Sun Y, Wu D. Feature extraction through local learning. Stat. Anal. Data Mining 2(1), 34-47 (2009).
39. Pittman J, Huang E, Dressman H et al. Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes. Proc. Natl Acad. Sci. USA 101(22), 8431-8436 (2004). (Pubitemid 38736592)
40. Ritz C. Comparing prognostic markers for metastases in breast cancer using artificial neural networks. Masters Thesis. Lund University, Sweden (2003).
41. Dettling M, Bühlmann P. Finding predictive gene groups from microarray data. J. Multivar. Anal. 90(1), 106-131 (2004). (Pubitemid 41137009)
42. Sun Y, Urquidi V, Goodison S. Derivation of molecular signatures for breast cancer recurrence prediction using a two-way validation approach. Breast Cancer Res. Treat. 119(3), 593-599 (2010).
43. Guyon I, Weston J, Barnhill S, Vapnik V. Gene selection for cancer classification using support vector machines. Mach. Learn. 46(1-3), 389-422 (2002). (Pubitemid 34129977)
44. Ng A. Feature selection, L1 vs L2 regularization, and rotational invariance. Proceedings of the 21st International Conference on Machine Learning. ACM International Conference Proceeding Series 69, 78 (2004).
45. Koziol JA, Feng AC, Jia Z et al. The wisdom of the commons: ensemble tree classifiers for prostate cancer prognosis. Bioinformatics 25(1), 54-60 (2009).
46. Stuart RO, Wachsman W, Berry CC et al. In silico dissection of cell-type-associated patterns of gene expression in prostate cancer. Proc. Natl Acad. Sci. USA 101(2), 615-620 (2004). (Pubitemid 38084685)
47. Cai Y, Sun Y, Li J, Goodison S. Online feature selection algorithm with bayesian l-1 regularization. Proceedings of 13th Pacific- Asia Conference on Knowledge Discovery and Data Mining (PAKDD09).Lecture Notes In Artificial Intelligence 5476, 401-413 (2009).
48. Febbo PG. Genomic approaches to outcome prediction in prostate cancer. Cancer 115(13 Suppl.), 3046-3057 (2009).
49. Welsh JB, Sapinoso LM, Su AI et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61(16), 5974-5978 (2001). (Pubitemid 32762523)
50. Dhanasekaran SM, Barrette TR, Ghosh D et al. Delineation of prognostic biomarkers in prostate cancer. Nature 412(6849), 822-826 (2001). (Pubitemid 32801464)
51. Luo J, Duggan DJ, Chen Y et al. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res. 61(12), 4683-4688 (2001). (Pubitemid 32691876)
52. Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J. Clin. Oncol. 17(5), 1499-1507 (1999). (Pubitemid 29220858)
53. Stephenson AJ, Scardino PT, Eastham JA et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J. Clin. Oncol. 23(28), 7005-7012 (2005).
54. Sun Y, Goodison S. Optimizing molecular signatures for predicting prostate cancer recurrence. Prostate 69(10), 1119-1127 (2009).
55. Sun Y, Todorovic S, Goodison S. Local learning based feature selection for high dimensional data analysis. IEEE Trans. Pattern Anal. Mach. Intell. (2010) (In Press).
56. Sun Y, Li J. Iterative relief for feature weighting. Proc. 23rd International Conference on Machine Learning (ICML06) 29, 1035-1051 (2006).
57. Sun Y, Cai Y, Goodison S. Combining nomogram and microarray data for predicting prostate cancer recurrence. Presented at: 8th IEEE International Conference on Bioinformatics and Bioengineering (BIBE08).Athens, Greece, 8-10 October 2008.
58. Cai Y, Sun Y, Cheng Y, Li J, Goodison S. Fast implementation of l1 regularized learning algorithms using gradient descent methods. Presented at: 10th SIAM International Conference on Data Mining (SDM).29 April-1 May, OH, USA, 2010.
59. Bandyopadhyay N, Kahveci T, Ranka S, Sun Y, Goodison S. Pathway based feature selection algorithm for cancer microarray data. Adv. Bioinformatics DOI: 10.1155/2009/532989 (2010) (Epub ahead of print).
60. Shendure J. The beginning of the end for microarrays? Nat. Methods 5(7), 585-587 (2008).
61. Ein-Dor L, Zuk O, Domany E. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc. Natl Acad. Sci. USA 103(15), 5923-5928 (2006).